January 30, 2021

Zou Lab's Cancer Cell Paper!

Congrats to the Zou lab for their new research paper, “Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance" and press release here!

Weiping Zou

Weiping Zou, M.D., Ph.D.

Charles B. de Nancrede Professor; Professor of Surgery, Immunology, and Biology
Director, Center of Excellence for Cancer Immunology and Immunotherapy
Co-Director, Cancer Hematopoiesis and Immunology Program
Director, Translational Research; Co-Director, Immune Monitoring Core
Accepting Students?